Relationship between IκBα constitutive expression, TNFα synthesis, and apoptosis in EBV-infected lymphoblastoid cells

Oncogene

Volumn 17, Issue 12, 1998, Pages 1607-1615

  Asso Bonnet, Marianne ^a   Feuillard, Jean ^a   Ferreira, Valérie ^b   Bissières, Philippe ^a   Tarantino, Nadine ^b   Körner, Marie ^b   Raphael, Martine ^a  

^a AVICENNE HOSPITAL   (France)

^b Laboratoire d'Immunologie Cellulaire et Tissulaire CNRS URA 625   (France)

Author keywords

EBV; I B ; NF B; TNF

Indexed keywords

BROXURIDINE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROPIDIUM IODIDE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; COMPLEMENTARY DNA; DNA BINDING PROTEIN; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA;

APOPTOSIS; ARTICLE; CELL CYCLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASM; DNA STRAND BREAKAGE; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LYMPHOBLASTOID CELL; NONHUMAN; PLASMID; PRIORITY JOURNAL; VIRUS CELL TRANSFORMATION; B LYMPHOCYTE; BIOSYNTHESIS; CELL DIVISION; CELL TRANSFORMATION; GENETICS; METABOLISM; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; VIROLOGY;

ALPHAVIRUS; HUMAN HERPESVIRUS 4;

APOPTOSIS; B-LYMPHOCYTES; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; CYTOKINES; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; HERPESVIRUS 4, HUMAN; HUMANS; I-KAPPA B PROTEINS; NF-KAPPA B; PHENOTYPE; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032563764     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202365     Document Type: Article

References (63)

1. Arenzana-Seisdedos F, Thompson J, Rodriguez MS, Bachelerie F, Thomas D and Hay RT. (1995). Mol. Cell. Biol., 15, 2689-2696.
2. Baeuerle PA and Baltimore D. (1989). Genes Dev., 3, 1689-1698.
3. Baeuerle PA and Henkel T. (1994). Ann., Rev. Immunol., 12, 141-179.
4. Beg AA and Baltimore D. (1996). Science, 274, 782-784.
5. Carrasco D, Rizzo CA, Dorfman K and Bravo R. (1996). EMBO J., 15, 3640-3650.
6. Collart MA, Baeuerle P and Vassalli P. (1990). Mol. Cell. Biol., 10, 1498-1506.
7. Coral S, Pucillo C, Leonardi A, Fonsatti E, Altomonte M and Maio M. (1997). Cell Growth Differ., 8, 581-588.
8. Cordingley FT, Bianchi A, Hoffbrand AV, Reittie JE, Heslop HE, Vyakarnam A, Turner M, Meager A and Brenner MK. (1988). Lancet, 1, 969-971.
9. Cressman DE and Taub R. (1993). Oncogene, 8, 2567-2573.
10. Ferreira V, Tarantino N and Korner M. (1998). J. Biol. Chem., 273, 592-599.
11. Feuillard J, Gouy H, Bismuth G, Lee LM, Debre P and Korner M. (1991). Cytokine, 3, 257-265.
12. Feuillard J, Taylor D, Casamayor-Palleja M, Johnson GD and MacLennan IC. (1995). Int. Immunol., 7, 121-130.
13. Goldfeld AE, Doyle C and Maniatis T. (1990). Proc. Nat. Acad. Sci. USA, 87, 9769-9773.
14. Goldfeld AE, Strominger JL and Doyle C. (1991). J Exp. Med, 174, 73-81.
15. Grilli M, Chiu JJ and Lenardo MJ. (1993). Internat. Rev. Cytol., 143, 1-62.
16. Grossman SR, Johannsen E, Tong X, Yalamanchili R and Kieff E. (1994). Proc. Nat. Acad. Sci. USA, 91, 7568-7572.
17. Henkel T, Lingj PD, Hayward SD and Peterson MG. (1994). Science, 265, 92-95.
18. Herrero JA, Mathew P and Paya CV. (1995). J. Virol., 69, 2168-2174.
19. Higgins KA, Perez JR, Coleman TA, Dorshkind K, McComas WA, Sarmiento UM, Rosen CA and Narayanan R. (1993). Proc. Natl. Acad. Sci. USA, 90, 9901-9905.
20. Houldsworth J, Mathew S, Rao PH, Dyomina K, Louie DC, Parsa N, Offit K and Chaganti RSK. (1996). Blood, 87, 25.
21. Hsieh JJ and Hayward SD. (1995). Science, 268, 560-563.
22. Huen DS, Henderson SA, Croom-Carter D and Rowe M. (1995). Oncogene, 10, 549-560.
23. Jaffray E, Wood KM and Hay RT. (1995). Mol. Cell. Biol., 15, 2166-2172.
24. Jelinek DF and Lipsky PE. (1987). J. Immunol., 139, 2970-2976.
25. Jochems GJ, Klein MR, Jordens R, Pascual-Salcedo D, van Boxtel-Oosterhof F, van Lier RA and Zeijlemaker WP. (1991). Hum. Antibodies Hybridomas, 2, 57-64.
26. Kaye KM, Devergne O, Harada JN, Izumi KM, Yalamanchili R, Kieff E and Mosialos G. (1996). Proc. Natl. Acad. Sci. USA, 93, 11085-11090.
27. Kehrl JH, Miller A and Fauci AS. (1987). J. Exp. Med., 166, 786-791.
28. Kieff E and Liebowtz D. (1990). Epstein-Barr virus and its replication, 2 edn. Raven Press, New York.
29. Klein SC, Kube D, Abts H, Diehl V and Tesch H. (1996). Leuk. Res., 20, 633-663.
30. Korner M, Bellan AH, Brini AT and Farrar WL. (1990). Biochem. J., 265, 547-554.
31. Laherty CD, Hu HM, Opipari AW, Wang F and Dixit VM. (1992). J. Biol. Chem., 267, 24157-24160.
32. Libermann TA and Baltimore D. (1990). Mol. Cell. Biol., 10, 2327-2334.
33. Liou HC, Nolan GP, Ghosh S, Fujita T and Baltimore D. (1992). EMBO J., 11, 3003-3009.
34. Lowe SW, Ruley HE, Jacks T and Housman DE. (1993). Cell, 74, 957-967.
35. Macia J, Gomez X, Esquerda A, Perez B, Callao V and Marzo C. (1996). Leuk Lymphoma, 20, 481-486.
36. McGuire W, Hill AV, Allsopp CE, Greenwood BM and Kwiatkowski D. (1994). Nature, 371, 508-510.
37. Migliazza A, Lombardi L, Rocchi M, Trecca D, Chang CC, Antonacci R, Fracchiolla NS, Ciana P, Maiolo AT and Neri A. (1994). Blood, 84, 3850-3860.
38. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C and Kieff E. (1995). Cell, 80, 389-399.
39. Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet Jr RJ, and Sledge Jr GW. (1997). Mol. Cell. Biol., 17, 3629-3639.
40. Neri A, Chang CC, Lombardi L, Salina M, Corradini P, Maiolo AT, Chaganti RS and Dalla-Favera R. (1991). Cell, 67, 1075-1087.
41. Osnes LT, Foss KB, Joo GB, Okkenhaug C, Westvik AB, Ovstebo R and Kierulf P. (1996). Thromb. Haemost., 76, 970-976.
42. Picker LJ, Singh MK, Zdraveski Z, Treer JR, Waldrop SL, Bergstresser PR and Maino VC. (1995). Blood, 86, 1408-1419.
43. Plaisance S, Vanden Berghe W, Boone E, Fiers W and Haegeman G. (1997). Mol. Cell. Biol., 17, 3733-3743.
44. Rothenberger S, Bachmann E, Berger C, McQuain C, Odermatt BF and Knecht H. (1997). Oncogene, 14, 2123-2126.
45. Salles G, Bienvenu J, Bastion Y, Barbier Y, Doche C, Warzocha K, Gutowski MC, Rieux C and Coiffier B. (1996). Br. J. Haematol., 93, 352-359.
46. Shackelford RE, Alford PB, Xue Y, Thai SF, Adams DO and Pizzo S. (1997). Mol. Pharmacol., 52, 421-429.
47. Shakhov AN, Collart MA, Vassalli P, Nedospasov SA and Jongeneel CV. (1990). J. Exp. Med., 171, 35-47.
48. Simek SL, Stephens RM and Rice NR. (1986). J. Virol., 59, 120-126.
49. Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM and Sonenshein GE. (1997). J. Clin. Invest., 100, 2952-2960.
50. Stephens RM, Rice NR, Hiebsch RR, Bose Jr HR and Gilden RV. (1983). Proc. Natl. Acad. Sci. USA, 80, 6229-6233.
51. Sugano N, Chen W, Roberts ML and Cooper NR. (1997). J. Exp. Med., 186, 731-737.
52. Sung SS, Jung LK, Walters JA, Chen W, Wang CY and Fu SM. (1988). J. Exp. Med., 168, 1539-1551.
53. Ten RM, Paya CV, Israel N, Le Bail O, Mattei MG, Virelizier JL, Kourilsky P and Israel A. (1992). EMBO J., 11, 195-203.
54. Traenckner EB, Pahl HL, Henkel T, Schmidt KN, Wilk S and Baeuerle PA. (1995). EMBO J., 14, 2876-2883.
55. Van Antwerp DJ, Martin SJ, Kafri T, Green DR and Verma IM. (1996). Science, 274, 787-789.
56. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D and Miyamoto S. (1995). Genes Dev., 9, 2723-2735.
57. Waltzer L, Bourillot PY, Sergeant A and Manet E. (1995). Nucleic Acids Res., 23, 4939-4945.
58. Wang CY, Mayo MW and Baldwin Jr AS. (1996). Science, 274, 784-787.
59. Warzocha K, Salles G, Bienvenu J, Barbier Y, Bastion Y, Doche C, Rieux C and Coiffier B. (1997a). Leukemia, 11, 441-443.
60. Warzocha K, Salles G, Bienvenu J, Bastion Y, Dumontet C, Renard N, Neidhardt-Berard EM and Coiffier B. (1997b). J. Clin. Oncol., 15, 499-508.
61. Wu F, Garcia J, Mitsuyasu R and Gaynor R. (1988). J. Virol., 62, 218-225.
62. Zabel U, Henkel T, Silva MS and Baeuerle PA. (1993). EMBO J., 12, 201-211.
63. Zimber-Strobl U, Strobl LJ, Meitinger C, Hinrichs R, Sakai T, Furukawa T, Honjo J and Bornkamm GW. (1994). EMBO J., 13, 4973-4982.